EcoDrugPlus

Glutamate Metabotropic Receptor 2

Ensembl ID : ENSNGAG00000015786
Gene Symbol: GRM2
3 Cross references
276 Possible Orthologues:

Glutamate Metabotropic Receptor 3

Ensembl ID : ENSNGAG00000023823
Gene Symbol: GRM3
3 Cross references
215 Possible Orthologues:

Glutamate Metabotropic Receptor 4

Ensembl ID : ENSNGAG00000010916
Gene Symbol: GRM4
3 Cross references
273 Possible Orthologues:

Glutamate Metabotropic Receptor 5

Ensembl ID : ENSNGAG00000000178
Gene Symbol: GRM5
3 Cross references
272 Possible Orthologues:

Glutamate Receptor, Ionotropic, Nmda2b (Epsilon 2)

Ensembl ID : ENSNGAG00000011619
Gene Symbol: GRIN2B
1 Cross references
330 Possible Orthologues:

Glutamate Receptor, Ionotropic, Nmda2d (Epsilon 4)

Ensembl ID : ENSNGAG00000018251
Gene Symbol: GRIN2D
1 Cross references
278 Possible Orthologues:

Glutaminase

Ensembl ID : ENSNGAG00000022784
Gene Symbol: GLS
3 Cross references
305 Possible Orthologues:

Glutathione S-Transferase P

Ensembl ID : ENSNGAG00000014047
Gene Symbol: LOC103725597
2 Cross references
172 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha

Ensembl ID : ENSNGAG00000018555
Gene Symbol: GSK3A
3 Cross references
260 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta

Ensembl ID : ENSNGAG00000002108
Gene Symbol: GSK3B
3 Cross references
241 Possible Orthologues:

Glycoprotein Vi Platelet

Ensembl ID : ENSNGAG00000014835
Gene Symbol: GP6
3 Cross references
135 Possible Orthologues:

Gonadotropin Releasing Hormone Receptor

Ensembl ID : ENSNGAG00000007122
Gene Symbol: GNRHR
3 Cross references
454 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).